Paediatric anaesthesia
-
Paediatric anaesthesia · Dec 2022
Multicenter StudySafety of Antifibrinolytics in 6583 Pediatric Patients Having Craniosynostosis Surgery: A Decade of Data Reported from the Multicenter Pediatric Craniofacial Collaborative Group.
Antifibrinolytics such as tranexamic acid and epsilon-aminocaproic acid are effective at reducing blood loss and transfusion in pediatric patients having craniofacial surgery. The Pediatric Craniofacial Collaborative Group has previously reported low rates of seizures and thromboembolic events (equal to no antifibrinolytic given) in open craniofacial surgery. ⋯ This multicenter international experience of pediatric craniofacial surgery reports no increase in seizures or thromboembolic events in those that received antifibrinolytics (tranexamic acid and epsilon-aminocaproic acid) versus those that did not. This report provides further evidence of antifibrinolytic safety. We recommend following pharmacokinetic-based dosing guidelines for administration.